Niagen Bioscience Inc (NAGE) Q1 FY26 Earnings Call

E-commerce growth and new-product launches support 10%-15% guidance, but NMN competition and higher marketing costs create near-term pressure.

Q1 FY26 results, source: company transcript and SEC filings
QuarterQ1 FY26
Call date2026-05-06
Length39 minutes
EPS$0.07
EPS consensus$0.06
Revenue$31.5M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All NAGE earnings ยท Back to NAGE overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.